Clinical trial / 2020
A novel nasal device reduced olfactory sensitivity, sweet preferences, and improved insulin metrics, with greater weight loss in adults aged 50 or younger.
Participants were randomized to wear a novel nasal device for 5-12 hours daily or receive daily saline nasal drops, alongside a 500 kcal/day reduced diet for 12 weeks. Sense of smell decreased from 6.4 ± 0.9 to 4.4 ± 1.5 in the device group (p < 0.001) with no change in controls. Overall weight loss was 6.6 ± 3.7% in the device group versus 5.7 ± 3.5% in controls (between-group p > 0.05), but was significantly greater with the device among participants aged ≤50 years (7.7 ± 4.2% vs. 4.1 ± 2.9%, p = 0.02). The device group also showed significant reductions in insulin, HOMA-IR, and preferences for sugar, sweet beverages, and artificial sweeteners.
- Study type
- Randomized, placebo-controlled study
- Who was studied
- 156 participants (65 completed the 12-week study)
- What was measured
- Olfactory sensitivity, body weight, food preferences, and metabolic parameters
THE PAPER
Weight Loss, Dietary Preferences, and Reduction in the Sense of Smell with the Use of a Novel Nasal Device.
Dicker D, Beck A, Markel A, Marcovicu D, Mazzawi S, Sarid M, Greenberg E, Atkinson RL. Obes Facts, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.